Rhenman & Partners Asset Management’s Outset Medical OM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,333	Closed	-$544K	–	93
2023 Q3	$544K	Sell	3,333 -18,709	-85%	-$4.42M	0.06%	83
2023 Q2	$7.23M	Sell	22,042 -15,291	-41%	-$4.66M	0.76%	44
2023 Q1	$10.2M	Buy	37,333 +13,333	+56%	+$4.89M	1.12%	33
2022 Q4	$9.3M	Buy	24,000 +1,333	+6%	+$376K	0.97%	39
2022 Q3	$5.28M	Buy	22,667 +10,667	+89%	+$2.86M	0.55%	56
2022 Q2	$2.67M	Buy	+12,000	New	+$5.16M	0.3%	69

Other funds holding OM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Rhenman & Partners Asset Management's OM Position: Q4 2023 in Review

Rhenman & Partners Asset Management sold out of Outset Medical (OM) in Q4 2023, closing a stake of 3,333 shares — an estimated $544K sold.

Rhenman & Partners Asset Management first reported a position in OM in Q2 2022 and held it in 6 quarters. The position peaked at $10.2M in Q1 2023. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

Rhenman & Partners Asset Management reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
Rhenman & Partners Asset Management sold 3,333 Outset Medical shares in Q4 2023, an estimated $544K.
Rhenman & Partners Asset Management first reported a position in Outset Medical in Q2 2022 and held it in 6 quarters.
Rhenman & Partners Asset Management's Outset Medical position peaked at $10.2M in Q1 2023.
140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Rhenman & Partners Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.